Utilizing the PTGS2/CTLA4 ratio, we stratified samples into high- and low-expression groups based on the median ratio to evaluate the impact on survival in multiple ovarian cancer cohorts (Figure 2). This evidence concerns the gene CTLA4 and ovarian cancer.